Zelnorm Related Clinical Trials
A Treatment Investigational New Drug (tIND) Program of Tegaserod in Women With Irritable Bowel Syndrome With Constipation or With Chronic Idiopathic Constipation [No longer available]
Effect of Tegaserod on Gastric Emptying in Patients With Diabetic Gastroparesis [Terminated]
Safety and Efficacy of Tegaserod in Opioid-Induced Constipation in Patients With Non-Cancer Pain. [Terminated]
The Effects of Tegaserod on Mechanical Sensitivity of the Esophagus and Stomach in Patients With Heartburn and Dyspepsia. [Completed]
The Effects of Tegaserod Vs. Placebo on Whole Gut Transit Time in Patients With Chronic Constipation and Dyspepsia [Withdrawn]
Efficacy, Safety and Tolerability of Tegaserod in Patients With Chronic Constipation [Completed]
Assessment of Efficacy and Safety of Tegaserod in Male Patients With Chronic Constipation. [Completed]
Preference of Tegaserod vs. PEG 3350 in Patients With Constipation [Completed]
Safety and Efficacy of Tegaserod in Opioid-Induced Constipation in Patients With Non-Cancer Pain. [Terminated]
An Evaluation of the Efficacy and Safety of Tegaserod 6 mg Bid Given Orally to Chinese Patients With Chronic Constipation [Completed]
Assessment of the Role of Tegaserod Therapy in the Management of Gastroesophageal Reflux Disease (GERD) Symptoms in Patients With Incomplete Response to Proton Pump Inhibitors (PPIs). [Completed]
Extension Study to Assess the Long-Term Safety of Tegaserod in Women With Symptoms of Dyspepsia [Completed]
Extension Study to Assess the Long-Term Safety of Tegaserod in Women With Symptoms of Dyspepsia [Completed]
The Role of Tegaserod Therapy in the Management of Dyspeptic Symptoms in Female Patients on Proton Pump Inhibitors for the Treatment of Heartburn. [Completed]
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Assess the Efficacy, Safety and Tolerability of Tegaserod 2 mg Bid vs Placebo in Patients With Chronic Constipation [Terminated]
Assessment of Efficacy and Safety of Tegaserod Treatment and Placebo in Women With Dyspepsia [Completed]
Assessment of Efficacy and Safety of Tegaserod Treatment and Placebo in Women With Dyspepsia [Completed]
Effect of Tegaserod on Orocecal Transit in Elderly Chronic Constipation Patients [Terminated]
Efficacy and Safety of Tegaserod in Opioid-Induced Constipation in Patients With Non-Cancer Pain [Terminated]
Assessment of the Effect of Tegaserod (2 mg Tid and 6 mg Tid) on Dyspeptic Symptoms in Diabetic Patients With Symptoms of Diabetic Gastropathy [Terminated]
Efficacy of Tegaserod in Relieving the Symptoms of Female Patients With Irritable Bowel Syndrome (IBS), Excluding Those With Predominant Diarrhea IBS [Completed]
The Effect of Tegaserod on Patterns of Flow in the Small Bowel of Patients With Irritable Bowel Syndrome (IBS) [Terminated]
Assessment of the Effects of Tegaserod in the Management of Gastroesophageal Reflux Disease (GERD) in Patients With Incomplete Response to Proton Pump Inhibitors (PPIs). [Completed]
Study of Effect of Tegaserod on Small and Large Bowel Transit by Scintigraphic Method [Recruiting]
A Study to Assess the Efficacy, Safety and Tolerability of Tegaserod Alone and in Combination With Omeprazole Given Orally in Patients With Symptoms of Symptomatic Gastroesophageal Reflux Disease (sGERD) [Completed]
Polyethyleneglycol3350 Vs Tegaserod in Treatment of Patients With Chronic Constipation [Completed]
|
